1. Home
  2. CRIS vs FEAM Comparison

CRIS vs FEAM Comparison

Compare CRIS & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • FEAM
  • Stock Information
  • Founded
  • CRIS 2000
  • FEAM 2016
  • Country
  • CRIS United States
  • FEAM United States
  • Employees
  • CRIS N/A
  • FEAM N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • FEAM Major Chemicals
  • Sector
  • CRIS Health Care
  • FEAM Industrials
  • Exchange
  • CRIS Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • CRIS 32.8M
  • FEAM 18.6M
  • IPO Year
  • CRIS 2000
  • FEAM N/A
  • Fundamental
  • Price
  • CRIS $3.22
  • FEAM $4.51
  • Analyst Decision
  • CRIS Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • CRIS 3
  • FEAM 2
  • Target Price
  • CRIS $23.00
  • FEAM $5.63
  • AVG Volume (30 Days)
  • CRIS 32.8K
  • FEAM 188.5K
  • Earning Date
  • CRIS 02-25-2025
  • FEAM 02-13-2025
  • Dividend Yield
  • CRIS N/A
  • FEAM N/A
  • EPS Growth
  • CRIS N/A
  • FEAM N/A
  • EPS
  • CRIS N/A
  • FEAM N/A
  • Revenue
  • CRIS $10,259,000.00
  • FEAM N/A
  • Revenue This Year
  • CRIS N/A
  • FEAM N/A
  • Revenue Next Year
  • CRIS N/A
  • FEAM $200.00
  • P/E Ratio
  • CRIS N/A
  • FEAM N/A
  • Revenue Growth
  • CRIS 0.44
  • FEAM N/A
  • 52 Week Low
  • CRIS $2.86
  • FEAM $4.65
  • 52 Week High
  • CRIS $17.49
  • FEAM $57.04
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 46.65
  • FEAM 28.73
  • Support Level
  • CRIS $3.10
  • FEAM $4.65
  • Resistance Level
  • CRIS $3.41
  • FEAM $8.33
  • Average True Range (ATR)
  • CRIS 0.18
  • FEAM 1.18
  • MACD
  • CRIS -0.00
  • FEAM -0.31
  • Stochastic Oscillator
  • CRIS 36.54
  • FEAM 1.81

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: